OutcomesTelling the Story - PowerPoint PPT Presentation

1 / 28
About This Presentation
Title:

OutcomesTelling the Story

Description:

ACI to double funding over 10 years for innovation-enabling research at ... Initial applications were in biotechnology, molecular electronics and other areas. ... – PowerPoint PPT presentation

Number of Views:37
Avg rating:3.0/5.0
Slides: 29
Provided by: centr130
Category:

less

Transcript and Presenter's Notes

Title: OutcomesTelling the Story


1
OutcomesTelling the Story
Jo Culbertson Office of the Assistant
Director for Engineering

2
Contacts for Major Discoveries and Events
  • Josh Chamot OLPA
  • Jchamot_at_nsf.gov
  • Jo Culbertson- ENG
  • Jculbert_at_nsf.gov

3
Accountability
  • NSF on the radar screen
  • What have you done for me lately?

4
Opportunity
  • ACI to double funding over 10 years for
    innovation-enabling research at NSF, DOE, and
    NIST
  • Agency funding tied to demonstrated contributions
    to society, potential for enhanced future
    economic growth

5
Building Better Bones
  • Researchers at the Georgia Tech/Emory Center for
    the Engineering of Living Tissues (GTEC) have
    developed a new minimally invasive technology for
    repairing bone defects and soft tissue injuries.
    A fast-gelling polymer can be injected to fill
    irregular gaps in a variety of tissues--bridging
    defects, stabilizing the damaged area, and
    promoting growth.

6
Building Better Bones
  • Cells and bioactive agents such as proteins can
    be embedded in the gel to promote enhanced
    regeneration of bone and nerve cells.
  • Among other uses, this technology offers a
    promising approach to treating spinal cord
    injuries, which are now largely untreatable.

7
Building Better Bones
  • (left) Intact spinal cord (center) Spinal cord
    with a cavity in dorsal spinal cord (right)
    Injury cavity filled with in situ gelling
    polymer. Permission Granted Credit Georgia
    Tech/Emory Center for the Engineering of Living
    Tissues

8
Highlights
  • Inform A/Cs, COVs, OMB, Congress, taxpayers about
    NSF-funded activities
  • Capture the essence of research and education at
    the frontiers and convey their excitement
  • Highlight emerging opportunities and challenges

9
Many Uses
  • Annual reporting of highlights for AC/ GPA review
    of NSF performance towards its strategic goals
  • Input to budget, briefings, talks, special events
    (NEES, sensors, robotics, airport security), NSF
    website, outreach to media

10
Many Uses
  • Promote public understanding of science and
    engineering
  • Recruit workforce of the future

11
Telling the Story
  • Clear and concise
  • Compelling images
  • 8th grade level
  • No jargon

12
WHY
  • Describe the problem/issue that motivated the
    research
  • What are the key knowledge gaps?

13
WHAT
  • Describe your results--tell what you achieved
    and put it in the context of other research

14
How
  • Describe your approach and why it is unique

15
WHO CARES?
  • Why is this result important?
  • How will it benefit society?

16
Hydrogen Storage Pulls Itself Together
  • Asemblon, Inc., a start-up company formed by
    researchers at the University of Washingtons
    Engineered Biomaterials Engineering Research
    Center (UWEB), is producing a new material with
    significant potential for storing and
    distributing hydrogena capability that's
    critical for deploying hydrogen-fueled cars and
    achieving greater energy self-sufficiency in the
    U.S.

17
Hydrogen Storage Pulls Itself Together
  • UWEB researchers developed the new
    materialcomprised of novel self-assembled
    monolayersand then formed Asemblon to produce
    and market it. Initial applications were in
    biotechnology, molecular electronics and other
    areas.

18
Hydrogen Storage Pulls Itself Together
  • Asemblon discovered that the material also allows
    hydrogen to be chemically stored and released to
    generate energy when it is needed. Once hydrogen
    has been released, the material can be recycled
    and re-used. Asemblon has established a separate
    division aimed at optimizing hydrogen storage
    capacity and release through its patented process
    and ultimately marketing the products.

19
A Self-Assembled Monolayer
  • Credit Dan Graham, Asemblon

20
Stay in Touch
  • Partners in disseminating the results of
    NSF-funded activities
  • Effective communication critical to future success

21
Undergraduate Creates Nano-Filter for Bio-Medical
Lab-on-a Chip
  • Nancy Guillen, undergraduate
  • B. Baird, PI
  • Cornell University
  • STC The Nanobiotechnology Center

22
WHAT
  • Nancy Guillen, an undergraduate at the
    University of Puerto Rico, Mayaguez, and a
    participant in the NSFs Research Experience for
    Undergraduates (REU) program, spent last summer
    with a Cornell University research team
    manufacturing and testing a collagen membrane
    that could one day be used as a miniaturized
    lab-on-a-chip for rapid screening of blood
    samples.

23
WHAT/HOW
  • Guillens membrane has nanometer-sized pores
    small enough to sift biomolecules by size alone.
    The membrane blocked hemoglobin while allowing
    DNA molecules to pass through.

24
WHAT/HOW
  • Guillens efforts broke new ground on several
    fronts. She used collagen monomers as raw
    material, which are up to 50 times thinner than
    the collagen fibrils used in commercially
    produced collagen membranes, and prepared them by
    the spin-deposition technique, which is also one
    of the easiest and cheapest ways to make the
    100-nanometer-thick membrane.

25
WHO CARES?
  • The successful use of collagen, the main
    connective tissue protein in the human body,
    offers the major advantage for the filter of
    biocompatibility meaning that implantable
    devices using Guillens membrane would be free
    from immune reactions.

26
WHO CARES?
  • For example, a coating for transplanted
    pancreatic islet tissues would let glucose and
    insulin pass through freely, but block the larger
    immune system molecules that lead to rejection.

27
WHO CARES
  • Biomedical devices using collagen membranes may
    thus someday free organ-transplant recipients
    from lifetime regimens of powerful
    immunosuppressant drugs.

28
WHO CARES?
  • The first uses of the filter will likely be to
    prepare DNA chips for quick medical analysis or
    newborn screening tests. Such a filter may also
    be used one day as part of implantable devices
    such as an artificial liver.
Write a Comment
User Comments (0)
About PowerShow.com